Inactivation of human immunodeficiency virus (HIV) by ionizing radiation in body fluids and serological evidence
Bigbee, P.D.; Sarin, P.S.; Humphreys, J.C.; Eubanks, W.G.; Sun, D.; Hocken, D.G.; Thornton, A.; Adams, D.E.; Simic, M.G.
Journal of Forensic Sciences 34(6): 1303-1310
1989
ISSN/ISBN: 0022-1198 PMID: 2584940 Document Number: 335985
A method to use ionizing radiation to inactivate HIV (Human Immunodeficiency Virus) in human body fluids was studied in an effort to reduce the risk of accidental infection to forensic science laboratory workers. Experiments conducted indicate that an X-ray absorbed dose of 25 krad was required to completely inactivate HIV. This does not alter forensically important constituents such as enzymes and proteins in body fluids. This method of inactivation of HIV cannot be used on body fluids which will be subjected to deoxyribonucleic acid (DNA) typing.
Document emailed within 1 workday
Related Documents
Kline, M.W.; Lewis, D.E.; Hollinger, F.B.; Reuben, J.M.; Hanson, L.C.; Kozinetz, C.A.; Dimitrov, D.H.; Rosenblatt, H.M.; Shearer, W.T. 1994: A comparative study of human immunodeficiency virus culture, polymerase chain reaction and anti-human immunodeficiency virus immunoglobulin A antibody detection in the diagnosis during early infancy of vertically acquired human immunodeficiency virus infection Pediatric Infectious Disease Journal 13(2): 90-94Koyanagi, A.; Humphrey, J.H.; Ntozini, R.; Nathoo, K.; Moulton, L.H.; Iliff, P.; Mutasa, K.; Ruff, A.; Ward, B.; Chidawanyika, H.; Hargrove, J.; Mahomva, A.I.; Majo, F.; Malaba, L.C.; Mbizvo, M.T.; Mzengeza, F.; Ndhlovu, M.; Piwoz, E.; Propper, L.; Rambanepasi, P.; Ruff, A.J.; Tavengwa, N.; Zijenah, L.S.; Zunguza, C.D.; Zvandasara, P. 2011: Morbidity among human immunodeficiency virus-exposed but uninfected, human immunodeficiency virus-infected, and human immunodeficiency virus-unexposed infants in Zimbabwe before availability of highly active antiretroviral therapy Pediatric Infectious Disease Journal 30(1): 45-51
Vzorov, A.N.; Dixon, D.W.; Trommel, J.S.; Marzilli, L.G.; Compans, R.W. 2002: Inactivation of human immunodeficiency virus type 1 by porphyrins Antimicrobial Agents and Chemotherapy 46(12): 3917-3925
Polsky, B.; Segal, S.J.; Baron, P.A.; Gold, J.W.; Ueno, H.; Armstrong, D. 1989: Inactivation of human immunodeficiency virus in vitro by gossypol Contraception 39(6): 579-587
Joshi, S.Kumar.; Ghimire, G.R. 2003: Serological prevalence of antibodies to human immunodeficiency virus (HIV) and hepatitis B virus (HBV) among healthy Nepalese males--a retrospective study Kathmandu University Medical Journal 1(4): 251-255
Shapshak, P.; McCoy, C.B.; Rivers, J.E.; Chitwood, D.D.; Mash, D.C.; Weatherby, N.L.; Inciardi, J.A.; Shah, S.M.; Brown, B.S. 1993: Inactivation of human immunodeficiency virus-1 at short time intervals using undiluted bleach Journal of Acquired Immune Deficiency Syndromes 6(2): 218-219
Samoĭlenko, I.I.; Kaloshin, P.M.; Tumanian, M.A. 1976: Inactivation of isogenous strains of Bacillus subtilis and their mixtures by ionizing radiation Mikrobiologiia 45(5): 864-868
Mokhbat, J.E.; Naman, R.E.; Rahme, F.S.; Farah, A.E.; Zahar, K.L.; Maalouf, A. 1989: Clinical and serological study of the human immunodeficiency virus infection in a cohort of multitransfused persons Le Journal Medical Libanais. Lebanese Medical Journal 38(1): 9-14
Kaplan, J.E.; Oleske, J.M.; Getchell, J.P.; Kalyanaraman, V.S.; Minnefor, A.B.; Zabala-Ablan, M.; Joshi, V.; Denny, T.; Cabradilla, C.D.; Rogers, M.F. 1985: Evidence against transmission of human T-lymphotropic virus/lymphadenopathy-associated virus (HTLV-III/LAV) in families of children with the acquired immunodeficiency syndrome Pediatric Infectious Disease 4(5): 468-471
Kaplan, J.E.; Oleske, J.M.; Getchell, J.P.; Kalyanaraman, V.S.; Minnefor, A.B.; Zabala-Ablan, M.; Joshi, V.; Denny, T.; Cabradilla, C.D.; Rogers, M.F. 1985: Evidence against transmission of human T-lymphotropic virus/lymphadenopathy-associated virus (HTLV-III/LAV) in families of children with the acquired immunodeficiency syndrome Pediatric Infectious Disease 4(5): 468-471
Ades, E.W.; Comans, T.W.; Nicholson, J.K.; Browning, S.W. 1993: Lack of evidence that human immunodeficiency virus can infect human endothelial cells in vitro Journal of Acquired Immune Deficiency Syndromes 6(1): 104
Koudriakova, T.; Iatsimirskaia, E.; Utkin, I.; Gangl, E.; Vouros, P.; Storozhuk, E.; Orza, D.; Marinina, J.; Gerber, N. 1998: Metabolism of the human immunodeficiency virus protease inhibitors indinavir and ritonavir by human intestinal microsomes and expressed cytochrome P4503A4/3A5: mechanism-based inactivation of cytochrome P4503A by ritonavir Drug Metabolism and Disposition: the Biological Fate of Chemicals 26(6): 552-561
Sabidó, M.; Lahuerta, M.; Montoliu, A.; Gonzalez, V.; Hernández, G.; Giardina, F.; Monzón, J.é E.; Pedroza, M.I.; Casabona, J. 2011: Human immunodeficiency virus, sexually transmitted infections, and risk behaviors among clients of sex workers in Guatemala: are they a bridge in human immunodeficiency virus transmission? Sexually Transmitted Diseases 38(8): 735-742
Yusim, K.; Peeters, M.; Pybus, O.G.; Bhattacharya, T.; Delaporte, E.; Mulanga, C.; Muldoon, M.; Theiler, J.; Korber, B. 2001: Using human immunodeficiency virus type 1 sequences to infer historical features of the acquired immune deficiency syndrome epidemic and human immunodeficiency virus evolution Philosophical Transactions of the Royal Society of London. Series B Biological Sciences 356(1410): 855-866
Rasheed, S.; Li, Z.; Xu, D.; Kovacs, A. 1996: Presence of cell-free human immunodeficiency virus in cervicovaginal secretions is independent of viral load in the blood of human immunodeficiency virus-infected women American Journal of Obstetrics and Gynecology 175(1): 122-129
Wen, Y.; Guan, J.; Wu, Z.; Li, L.; Rotheram-Borus, M.Jane.; Lin, C.; Detels, R. 2009: Pharmacy workers' sexually transmitted diseases/human immunodeficiency virus knowledge in Fuzhou, China: implications for human immunodeficiency virus testing, treatment, and prevention strategies Sexually Transmitted Diseases 36(4): 221-226
Anonymous 1988: 1988 agent summary statement for human immunodeficiency virus and report on laboratory-acquired infection with human immunodeficiency virus Morbidity and Mortality Weekly Report 37(S-4): 22
Franke, M.F.; Stulac, S.N.; Rugira, I.H.; Rich, M.L.; Bucyibaruta, J.B.; Drobac, P.C.; Iyamungu, G.; Bryant, C.M.; Binagwaho, A.; Farmer, P.E.; Mukherjee, J.S. 2011: High human immunodeficiency virus-free survival of infants born to human immunodeficiency virus-positive mothers in an integrated program to decrease child mortality in rural Rwanda Pediatric Infectious Disease Journal 30(7): 614-616
Monteiro, J.P.; Freimanis-Hance, L.; Faria, L.B.; Mussi-Pinhata, M.M.; Korelitz, J.; Vannucchi, H.él.; Queiroz, W.; Succi, R.C.M.; Hazra, R. 2009: Both human immunodeficiency virus-infected and human immunodeficiency virus-exposed, uninfected children living in Brazil, Argentina, and Mexico have similar rates of low concentrations of retinol, beta-carotene, and vitamin e Nutrition Research 29(10): 716-722
Kidangazhiayathmana, A. 2011: Is Kerala remaining low prevalent in human immunodeficiency virus by accident? a study of risk factors in acquiring human immunodeficiency virus infection in patients attending Anti-retroviral treatment clinic Indian Journal of Dermatology Venereology and Leprology 77(6): 729